Cambridge Biotech adopts new trading name:
This article was originally published in Clinica
Cambridge Biotech is to change its name to Cambridge Diagnostics Ireland, reflecting its location in Galway, Ireland. Cambridge Biotech was acquired by Massachusetts-based Selfcare in November 1994 (see Clinica No 632, p 14). The Galway facility is responsible for the manufacture of, among other assays, Capillus, Recombigen HIV 1/2 and Hepatitis Delta.